Effectiveness of lipid-lowering therapy in primary care in France

被引：0
作者：
van Ganse, E
Moulin, P
Bertrand, M
Souchet, T
Pietri, G
Alemao, E
Yin, D
de Pouvourville, G
机构：
[1] Louis Pradel Hosp, Lyon Sud Hosp, Lyon, France
[2] Lille Univ Hosp, Lille, France
[3] Merck Sharp & Dohme Ltd, Paris, France
[4] INSERM, U537, Paris, France
[5] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
[21]   The Future of Lipid-Lowering Therapy [J].
van Zwol, Willemien ;
Rimbert, Antoine ;
Kuivenhoven, Jan Albert .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07)
[22]   LIPID-LOWERING MEDICATION USE BY PRIMARY-CARE PHYSICIANS [J].
KEYSERLING, TC ;
METCALF, PA ;
DAVIS, CE ;
AMMERMAN, AS ;
SIMPSON, RJ .
CIRCULATION, 1993, 88 (04) :635-635
[23]   Lipid-lowering therapy for the primary prevention of coronary heart disease [J].
Gotto, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) :2078-2082
[24]   Cost effectiveness of lipid-lowering therapy: Let's get real [J].
Drummond, M .
PHARMACOECONOMICS, 2004, 22
[25]   Cost effectiveness of lipid-lowering therapy: Let’s get real [J].
Michael Drummond .
PharmacoEconomics, 2004, 22 (Suppl 3) :i-ii
[26]   Secondary prevention of ischemic heart disease in the Ciudad Real province, Spain.: Effectiveness of lipid-lowering therapy in primary health care [J].
Villar, B ;
Rodríguez, C ;
Rodríguez, C ;
Javier, F ;
Fernández, DB ;
Luis, J ;
Sánchez-Mingallón, D ;
del Pulgar, GG ;
García, G ;
del Valle, G ;
Fernández, I ;
Moyano, M ;
Sánchez, P ;
Fermín, A ;
Olmo, R ;
Jesús, M ;
Serrano, R ;
Lorenzo, A ;
Higueruelo, S ;
Consuegra, T ;
Alcántara, Z .
MEDICINA CLINICA, 2000, 115 (09) :321-325
[27]   THE PROBLEM OF SAFETY OF LIPID-LOWERING THERAPY [J].
Zykov, M., V .
KARDIOLOGIYA, 2019, 59 (05) :13-26
[28]   LIPID-LOWERING THERAPY STRIKES AGAIN [J].
Pantea, R. ;
Zara, C. ;
Chirita-Emandi, A. ;
Ivascu, M. ;
Balahura, A. -M. .
ATHEROSCLEROSIS, 2023, 379 :S171-S171
[29]   Lipid-lowering therapy in membranous nephropathy [J].
Haas, M ;
Kerjaschki, D ;
Mayer, G .
KIDNEY INTERNATIONAL, 1999, 56 :S110-S112
[30]   New and emerging lipid-lowering therapy [J].
Backes, James M. ;
Hilleman, Daniel E. .
FUTURE CARDIOLOGY, 2021, 17 (08) :1407-1420
12345